BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 485993)

  • 1. Prepubertal cyclophosphamide therapy and gonadal dysfunction: a case report and review of the literature.
    Alfiler CA
    Aust Paediatr J; 1979 Jun; 15(2):120-3. PubMed ID: 485993
    [No Abstract]   [Full Text] [Related]  

  • 2. Testicular function in prepubertal and pubertal male patients treated with cyclophosphamide for nephrotic syndrome.
    Penso J; Lippe B; Ehrlich R; Smith FG
    J Pediatr; 1974 Jun; 84(6):831-6. PubMed ID: 4826616
    [No Abstract]   [Full Text] [Related]  

  • 3. Gonadal function in males treated with cyclophosphamide for nephrotic syndrome.
    Hsu AC; Folami AO; Bain J; Rance CP
    Fertil Steril; 1979 Feb; 31(2):173-7. PubMed ID: 761678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty.
    Lentz RD; Bergstein J; Steffes MW; Brown DR; Prem K; Michael AF; Vernier RL
    J Pediatr; 1977 Sep; 91(3):385-94. PubMed ID: 894406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide and the prepubertal testis.
    Arneil GC
    Lancet; 1972 Dec; 2(7789):1259-60. PubMed ID: 4117757
    [No Abstract]   [Full Text] [Related]  

  • 6. Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study.
    Watson AR; Taylor J; Rance CP; Bain J
    Fertil Steril; 1986 Aug; 46(2):331-3. PubMed ID: 3732541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide pulse therapy in relapsing nephrotic syndrome.
    Wardle EN
    Nephron; 1991; 58(3):377. PubMed ID: 1896110
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cyclophosphamide on children with steroid resistant nephrotic syndrome and its side effect upon the gonadal tissue.
    Wila W; Alatas H; Tambunan T; Khow LP; Ramelan W
    Paediatr Indones; 1976; 16(7-8):291-8. PubMed ID: 1004929
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclophosphamide in the treatment of adult nephrotic syndrome.
    Gulati PD; Rizvi SN; Ajmani SK; Bhasin RC; Vaishnava H
    J Assoc Physicians India; 1973 Jan; 21(1):23-9. PubMed ID: 4792697
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-term effects of cyclophosphamide therapy in treatment of the "primary" nephrotic syndrome of childhood].
    Lama G
    Pediatria (Napoli); 1976 Jun; 84(2):320-30. PubMed ID: 798171
    [No Abstract]   [Full Text] [Related]  

  • 11. Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome.
    Etteldorf JN; West CD; Pitcock JA; Williams DL
    J Pediatr; 1976 Feb; 88(2):206-12. PubMed ID: 1249681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide and the nephrotic syndrome.
    Drummond KN
    Br Med J; 1969 May; 2(5656):576-7. PubMed ID: 5769897
    [No Abstract]   [Full Text] [Related]  

  • 13. Pituitary-gonadal function in women following cyclophosphamide treatment for childhood nephrotic syndrome: long-term follow-up study.
    Bogdanović R; Banićević M; Cvorić A
    Pediatr Nephrol; 1990 Sep; 4(5):455-8. PubMed ID: 2242304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Long term use of cyclophosphamide in nephrotic syndrome".
    Choudhary VP
    Indian Pediatr; 1978 Apr; 15(4):369. PubMed ID: 711307
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide therapy in adults with minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Jun; 1(7763):1250-3. PubMed ID: 4113514
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide in the treatment of childhood nephrotic syndrome.
    Wiggelinkhuizen J; McDonald R; Kaschula RO
    S Afr Med J; 1972 Sep; 46(39):1417-23. PubMed ID: 4642675
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide in pregnancy.
    Coates A
    Aust N Z J Obstet Gynaecol; 1970 Feb; 10(1):33-4. PubMed ID: 5269081
    [No Abstract]   [Full Text] [Related]  

  • 18. Gonadotropin responses to luteinizing releasing factor in boys treated with cyclophosphamide for nephrotic syndrome.
    Kirkland RT; Bongiovanni AM; Cornfield D; McCormick JB; Parks JS; Tenore A
    J Pediatr; 1976 Dec; 89(6):941-4. PubMed ID: 792411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide in minimal-change nephrotic syndrome.
    Uldall PR; Feest TG; Morley AR; Tomlinson BE; Kerr DN
    Lancet; 1972 Sep; 2(7776):537-8. PubMed ID: 4115589
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children.
    Lancet; 1974 Aug; 2(7878):423-7. PubMed ID: 4137139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.